These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6436858)

  • 21. Response of borderline patients to loxapine and chlorpromazine.
    Leone NF
    J Clin Psychiatry; 1982 Apr; 43(4):148-50. PubMed ID: 7040351
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple neuroendocrinological responses in borderline personality disorder patients.
    Kontaxakis V; Markianos M; Vaslamatzis G; Markidis M; Kanellos P; Stefanis C
    Acta Psychiatr Scand; 1987 Nov; 76(5):593-7. PubMed ID: 3124503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.
    Goldberg SC; Schulz SC; Schulz PM; Resnick RJ; Hamer RM; Friedel RO
    Arch Gen Psychiatry; 1986 Jul; 43(7):680-6. PubMed ID: 3521531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic treatment in the borderline patient: advantages and techniques.
    Soloff PH
    J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients.
    Marangell LB; George MS; Callahan AM; Ketter TA; Pazzaglia PJ; L'Herrou TA; Leverich GS; Post RM
    Arch Gen Psychiatry; 1997 Mar; 54(3):214-22. PubMed ID: 9075462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopharmacology of borderline personality disorder: a review.
    Cowdry RW
    J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment utilization by patients with personality disorders.
    Bender DS; Dolan RT; Skodol AE; Sanislow CA; Dyck IR; McGlashan TH; Shea MT; Zanarini MC; Oldham JM; Gunderson JG
    Am J Psychiatry; 2001 Feb; 158(2):295-302. PubMed ID: 11156814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open, noncomparative study of amoxapine in borderline disorders.
    Jensen HV; Andersen J
    Acta Psychiatr Scand; 1989 Jan; 79(1):89-93. PubMed ID: 2648768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imipramine treatment of borderline children: case reports with a controlled study.
    Petti TA; Unis A
    Am J Psychiatry; 1981 Apr; 138(4):515-8. PubMed ID: 7011062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depression.
    Möller HJ; Kissling W; Herberger B; Binz U; Wendt G; Spahn H
    Pharmacopsychiatry; 1986 Sep; 19(5):362-4. PubMed ID: 3534899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRH stimulation and dexamethasone suppression in borderline personality disorder.
    De la Fuente JM; Mendlewicz J
    Biol Psychiatry; 1996 Sep; 40(5):412-8. PubMed ID: 8874844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients.
    Fava M; Rosenbaum JF; Birnbaum R; Kelly K; Otto MW; MacLaughlin R
    Acta Psychiatr Scand; 1992 Jul; 86(1):42-5. PubMed ID: 1414398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug therapy in borderline patients.
    Cole JO; Salomon M; Gunderson J; Sunderland P; Simmonds P
    Compr Psychiatry; 1984; 25(3):249-54. PubMed ID: 6145541
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression.
    Szuba MP; Amsterdam JD; Fernando AT; Gary KA; Whybrow PC; Winokur A
    J Clin Psychopharmacol; 2005 Aug; 25(4):325-30. PubMed ID: 16012274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug treatment of the personality disorders.
    Stein G
    Br J Psychiatry; 1992 Aug; 161():167-84. PubMed ID: 1355689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.
    Pinto OC; Akiskal HS
    J Affect Disord; 1998 Dec; 51(3):333-43. PubMed ID: 10333987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRH by slow, continuous infusion: an antidepressant?
    van den Burg W; van Praag HM; Bos ER; Piers DA; van Zanten AK; Doorenbos H
    Psychol Med; 1976 Aug; 6(3):393-7. PubMed ID: 825895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral dyscontrol in borderline patients treated with amitriptyline.
    Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
    Psychopharmacol Bull; 1987; 23(1):177-81. PubMed ID: 3602316
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of DST and TRH test administration on depression assessments: a controlled study.
    Lafer B; Fava M; Hammerness P; Rosenbaum JF
    Biol Psychiatry; 1993 Nov; 34(9):650-3. PubMed ID: 8292694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.